CSIMarket Company Name, Ticker, Suppliers, else..
 


Biotechnology & Pharmaceuticals Industry Growth Rates

Revenue, Income, Cash Flow and Capital Expenditure Growth Information & Trends 
 


Category:  

 
Biotechnology & Pharmaceuticals Industry 1 Q 4 Q 3 Q 2 Q 1 Q
  Q1 2025 FY 2024 and Q4 2024 Q3 2024 Q2 2024 Q1 2024
Y / Y Revenue Quarterly Growth 11.96 % -2.05 % 13.5 % 12.11 % -1.28 %
Sequential Revenue Quarterly Growth -9.83 % 0.17 % 9.64 % 12.35 % -21 %
Revenue Growth Overall Ranking Y/Y # 11 # 75 # 13 # 11 # 62
Y / Y Revenue Annual Growth (at the end of Fiscal Year) 5.11 %
Y / Y Revenue Growth (12 Months at Quarter Ending) 5.32 % 5.11 % 5.4 % -0.54 % -7.13 %
Sequential Revenue Growth (12 Months at Quarter Ending) 2.5 % -0.69 % 3.21 % 2.74 % -0.36 %
Revenue Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81
Y / Y Operating Income Quarterly Growth - 34.86 % 331.4 % 129.77 % -
Sequential Operating Income Quarterly Growth 3.08 % 62.8 % -27.52 % - -
Operating Income Overall Ranking Y/Y # 11 # 75 # 14 # 10 # 62
Y / Y Operating Income Annual Growth (at the end of Fiscal Year) - -71.9 % - -
Y / Y Operating Income Growth (12 Months trailing by quarter ending) - -71.9 % -91.61 % - -
Sequential Operating Income Growth (12 Months trailing by quarter ending) - 46.28 % - - -
Operating Income Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81
Y / Y Income from Cont. Ops Quarterly Growth - -75.33 % - - -
Sequential Income from Cont. Ops Quarterly Growth - -86.45 % 383.5 % - -
Income from Cont. Ops Overall Ranking Y/Y # 11 # 75 # 14 # 10 # 62
Y / Y Income from Cont. Ops Annual Growth (at the end of Fiscal Year) - - - - -
Y / Y Income from Cont. Ops Growth (12 Months trailing by quarter ending) - - - - -
Sequential Income from Cont. Ops Growth (12 Months trailing by quarter ending) - - - - -
Income from Cont. Ops Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81
Y / Y Net Income Quarterly Growth - -75.08 % - - -
Sequential Net Income Quarterly Growth - -86.45 % 383.36 % - -
Net Income Overall Ranking Y/Y # 11 # 75 # 14 # 10 # 62
Y / Y Net Income Annual Growth (at the end of Fiscal Year) - - - - -
Y / Y Net Income Growth (12 Months trailing by quarter ending) - - - - -
Sequential Net Income Growth (12 Months trailing by quarter ending) - - - - -
Net Income Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81
Y / Y Free Cash Flow Quarterly Growth - 252.94 % 168.78 % -45.2 % 1849.97 %
Sequential Free Cash Flow Quarterly Growth - 38.66 % 142.7 % 104.04 % -51.44 %
Free Cash Flow Overall Ranking Y/Y # 11 # 75 # 14 # 10 # 62
Y / Y Free Cash Flow Annual Growth (at the end of Fiscal Year) 71.29 %
Y / Y Free Cash Flow Growth (12 Months trailing by quarter ending) 76.76 % 71.29 % 0.77 % -38.43 % -38.11 %
Sequential Free Cash Flow Growth (12 Months trailing by quarter ending) -9.99 % 41.12 % 33 % -14.6 % 6.42 %
Free Cash Flow Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81
Y / Y Capital Expenditures Quarterly Growth -29.54 % 34.67 % 3.71 % -22.2 % -8.44 %
Sequential Capital Expenditures Quarterly Growth -57.24 % 54.93 % 5.61 % -7.85 % -11.9 %
Capital Expenditures Overall Ranking Y/Y # 11 # 75 # 14 # 10 # 62
Y / Y Capital Expenditures Annual Growth (at the end of Fiscal Year) 3.5 %
Y / Y Capital Expenditures Growth (12 Months trailing by quarter ending) -1.81 % 3.5 % 5.33 % 7.72 % 14.14 %
Sequential Capital Expenditures Growth (12 Months trailing by quarter ending) -7.09 % 10.94 % 0.36 % -4.77 % -2.33 %
Capital Expenditures Growth Ranking Y/Y (TTM) # 46 # 43 # 40 # 58 # 81

New: More Biotechnology & Pharmaceuticals Industrys' historic Revenue growth >>

Revenue growth Comment
Biotechnology & Pharmaceuticals Industry's pace of Revenue growth in 1 Q 2025 accelerated to 11.96 % year on year, above Industry average.

Sequentially Revenue fell by -9.83 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Revenue growth. Revenue growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.



Revenue Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Revenue Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Revenue Y/Y Growth

 


Revenue Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Revenue growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry's pace of cumulative 12 months Sales growth in 1 Q 2025 accelerated to 5.32 % year on year, but remained below Industry average.

Sequentially TTM Revenue grew by 2.5 %.

Within Healthcare sector 2 other industries have achieved higher Revenue growth. Revenue growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Revenue Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46

Biotechnology & Pharmaceuticals Industry Operating Income Y/Y Growth

Operating Income growth Comment
Biotechnology & Pharmaceuticals Industry achieved Operating Income in 1 Q 2025.

Sequentially Operating Income grew by 3.08 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Operating Income growth. Operating Income growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 



Operating Income Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Operating Income Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Operating Income Y/Y Growth

 


Operating Income Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Operating Income growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry achieved Operating Income in 1 Q 2025.

Sequentially cumulative Operating Income fell by -148.23 %.

Within Healthcare sector 2 other industries have achieved higher Operating Income growth. Operating Income growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Operating Income Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46

Biotechnology & Pharmaceuticals Industry Income from Cont. Ops Y/Y Growth

Income from Cont. Ops growth Comment




Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Income from Cont. Ops growth. Income from Cont. Ops growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 



Income from Cont. Ops Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Income from Cont. Ops Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Income from Cont. Ops Y/Y Growth

 


Income from Cont. Ops Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Income from Cont. Ops growth Y/Y TTM Comment
On the trailing twelve months basis




Within Healthcare sector 2 other industries have achieved higher Income from Cont. Ops growth. Income from Cont. Ops growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Income from Cont. Ops Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46

Biotechnology & Pharmaceuticals Industry Net Income Y/Y Growth

Net Income growth Comment




Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Net Income growth. Net Income growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 



Net Income Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Net Income Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Net Income Y/Y Growth

 


Net Income Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Net Income growth Y/Y TTM Comment
On the trailing twelve months basis




Within Healthcare sector 2 other industries have achieved higher Net Income growth. Net Income growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Net Income Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46

Biotechnology & Pharmaceuticals Industry Free Cash Flow Y/Y Growth

Free Cash Flow growth Comment




Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Free Cash Flow growth. Free Cash Flow growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 



Free Cash Flow Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Free Cash Flow Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Free Cash Flow Y/Y Growth

 


Free Cash Flow Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Free Cash Flow growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry's pace of cumulative 12 months Free Cash Flow growth in 1 Q 2025 accelerated to 76.76 % year on year, above Industry average.



Within Healthcare sector 2 other industries have achieved higher Free Cash Flow growth. Free Cash Flow growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Free Cash Flow Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46

Biotechnology & Pharmaceuticals Industry Capital Expenditures Y/Y Growth

Capital Expenditures growth Comment
Biotechnology & Pharmaceuticals Industry realized contraction in Capital Expenditures by -29.54 % in 1 Q 2025 year on year.

Sequentially Capital Expenditures fell by -57.24 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Capital Expenditures growth. Capital Expenditures growth total ranking has improved so far to 11, from total ranking in previous quarter at 75.

 



Capital Expenditures Y/Y Growth Statistics
High
Average
Low
41.92 % 9.65 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Capital Expenditures Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 11



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Capital Expenditures Y/Y Growth

 


Capital Expenditures Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.39 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Capital Expenditures growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry faced contraction in cumulative twelve months Capital Expenditures by -1.81 % in 1 Q 2025 year on year.

Sequentially cumulative Capital Expenditures fell by -7.09 %.

Within Healthcare sector 2 other industries have achieved higher Capital Expenditures growth. Capital Expenditures growth total ranking has declined compared to a quarter before from 43 to 46.

Industry Capital Expenditures Y/Y Growth Ranking Annual
Within: No.
Sector # 3
Overall Market # 46





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com